Led by former Nimbus executive Rosana Kapeller, the startup has now raised nearly $200 million in its pursuit of new autoimmune disease and cancer therapies.When Rosana Kapeller was working at Nimbus Therapeutics in the early 2010s, the technology to study the so-called dark genome didn’t exist.Fourteen years later, Kapeller is running a biotechnology startup well […]
